BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20200941)

  • 1. The type 2 deiodinase Thr92Ala polymorphism is associated with increased bone turnover and decreased femoral neck bone mineral density.
    Heemstra KA; Hoftijzer H; van der Deure WM; Peeters RP; Hamdy NA; Pereira A; Corssmit EP; Romijn JA; Visser TJ; Smit JW
    J Bone Miner Res; 2010 Jun; 25(6):1385-91. PubMed ID: 20200941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis.
    Heemstra KA; Hoftijzer HC; van der Deure WM; Peeters RP; Fliers E; Appelhof BC; Wiersinga WM; Corssmit EP; Visser TJ; Smit JW
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):279-83. PubMed ID: 19018782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen Ialpha1 Sp1 polymorphism, bone mass, and bone turnover in healthy French premenopausal women: the OFELY study.
    Garnero P; Borel O; Grant SF; Ralston SH; Delmas PD
    J Bone Miner Res; 1998 May; 13(5):813-7. PubMed ID: 9610745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
    J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
    Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD
    Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 deiodinase Thr92Ala polymorphism is associated with disrupted placental activity but not with dysglycemia or adverse gestational outcomes: a genetic association study.
    Dora JM; Wajner SM; Costa JD; Pinto Ribeiro RV; Leiria LB; Lopes MG; Vitali da Silva A; Crispim D; Maia AL
    Fertil Steril; 2014 Mar; 101(3):833-9. PubMed ID: 24355051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters.
    Peeters RP; van den Beld AW; Attalki H; Toor Hv; de Rijke YB; Kuiper GG; Lamberts SW; Janssen JA; Uitterlinden AG; Visser TJ
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E75-81. PubMed ID: 15727947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus.
    Canani LH; Capp C; Dora JM; Meyer EL; Wagner MS; Harney JW; Larsen PR; Gross JL; Bianco AC; Maia AL
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3472-8. PubMed ID: 15797963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation.
    Giannini S; D'Angelo A; Nobile M; Carraro G; Rigotti P; Silva-Netto F; Pavan S; Marchini F; Zaninotto M; Dalle Carbonare L; Sartori L; Crepaldi G
    J Bone Miner Res; 2002 Oct; 17(10):1768-73. PubMed ID: 12369780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men.
    Gonnelli S; Caffarelli C; Del Santo K; Cadirni A; Guerriero C; Lucani B; Franci B; Nuti R
    Calcif Tissue Int; 2008 Jul; 83(1):55-60. PubMed ID: 18563283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis.
    Lormeau C; Soudan B; d'Herbomez M; Pigny P; Duquesnoy B; Cortet B
    Bone; 2004 Jun; 34(6):933-9. PubMed ID: 15193539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma.
    Heemstra KA; van der Deure WM; Peeters RP; Hamdy NA; Stokkel MP; Corssmit EP; Romijn JA; Visser TJ; Smit JW
    Eur J Endocrinol; 2008 Jul; 159(1):69-76. PubMed ID: 18390987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased formation of 8-iso-prostaglandin F(2alpha) is associated with altered bone metabolism and lower bone mass in hypercholesterolaemic subjects.
    Mangiafico RA; Malaponte G; Pennisi P; Li Volti G; Trovato G; Mangiafico M; Bevelacqua Y; Mazza F; Fiore CE
    J Intern Med; 2007 Jun; 261(6):587-96. PubMed ID: 17547714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 deiodinase Thr92Ala polymorphism is associated with a reduction in bone mineral density: A community-based korean genome and epidemiology study.
    Kang YE; Kang YM; Park B; Shong M; Yi HS
    Clin Endocrinol (Oxf); 2020 Sep; 93(3):238-247. PubMed ID: 32324283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of reduced bone mineral density and increased bone turnover after kidney transplantation: cross-sectional study.
    Kusec V; Smalcelj R; Cvijetić S; Rozman B; Skreb F
    Croat Med J; 2000 Dec; 41(4):396-400. PubMed ID: 11063762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.